This indicates a potential role for the TIM-3/Gal-9 pathway in myeloid/T cells interaction that enhances the regulatory phenotype of myeloid cells in progressive patients, as observed in cancer patients37,38. The gene discussed is HAVCR2; the disease is cancer.